Christopher Shelton

Christopher Shelton

Company: GlaxoSmithKline

Job title: Scientific Director, Tumor Cell Targeting Research Unit

Seminars:

Strategies to Maximize the Effectiveness of Belantamab Mafodotin 9:30 am

Leveraging antibody effector functions in combination with cytotoxic payloads Discussing manipulation of cell surface levels of target to maximize potency Examining the effect of DAR on efficacyRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.